Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

SETISIN INJECTION 2.5 mg/ml

Approval Number

SIN10993P

Drug Name

SETISIN INJECTION 2.5 mg/ml

Product Name

SETISIN INJECTION 2.5 mg/ml

Approval Date

June 26, 1999

Registrant

DUOPHARMA (SINGAPORE) PTE LTD

Licence Holder

DUOPHARMA (SINGAPORE) PTE LTD

Regulatory Information

Registrant

DUOPHARMA (SINGAPORE) PTE LTD

Licence Holder

DUOPHARMA (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION

Route of Administration

INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR

Medical Information

ATC Code

N07AA01

ATC Item Name

neostigmine

Manufacturer Information

Pharmaceutical Manufacturer

DUOPHARMA (SINGAPORE) PTE. LTD.

Manufacturers

DUOPHARMA (M) SDN BHD

Active Ingredients

Ingredient Name

NEOSTIGMINE METHYLSULPHATE

Strength

2.5 mg/ml

Drug MonographNeostigmine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

SETISIN INJECTION 2.5 mg/ml - HSA Approval | MedPath